EIKN
Eikon Therapeutics, Inc.
Eikon Therapeutics, Inc. insider trading
Insiders at Eikon Therapeutics, Inc. have been buying its stock on the open market. The largest purchase in the last 30 days was Column Group IV GP, LP (10% Owner) buying $1M of EIKN, filed Sep 08, 2026. Every open-market purchase and sale its officers, directors and 10% owners filed in that time is listed below, each linked to the original Form 4.
- Bought on the open market
- $1M
- Sold
- —
- Insiders
- 1
- Latest trade
- Sep 03, 2026
From SEC filings · last 30 days
Recent EIKN insider transactions
Column Group IV GP, LP10% Owner
Bought 89,200 sh at $11.56 · Sep 03, 2026
$1M
Filing
SEC Form 4 data, Q3 2024 to Q2 2026
EIKN insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 4 insiders traded EIKN on the open market: 6 purchases worth $43.6M and 0 sales. In the last four quarters alone: 6 purchases ($43.6M) and 0 sales, by 4 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | — | |
| Q1 2026 | +$43.6M6 buys | — | |
| Q4 2025 | — | — | |
| Q3 2025 | — | — | |
| Q2 2025 | — | — | |
| Q1 2025 | — | — | |
| Q4 2024 | — | — | |
| Q3 2024 | — | — |
- Largest purchase
- +$25.9M of EIKN by Column Group Opportunity III, LP (10% Owner) on Feb 06, 2026.
Open-market transactions through Jun 30, 2026most recent first
Column Group Opportunity III, LP
10% Owner
+$25.9M
Feb 06, 2026
1,437,323 sh · $18.00
Column Group Opportunity III, LP
10% Owner
+$11.4M
Feb 06, 2026
630,881 sh · $18.00
Column Group Opportunity III, LP
10% Owner
+$892K
Feb 06, 2026
49,556 sh · $18.00
Wolfe Josh
Director · 10% Owner
+$2.5M
Feb 04, 2026
138,888 sh · $18.00
Frazier Kenneth C
Director
+$2M
Feb 04, 2026
111,111 sh · $18.00
Foresite Capital Opportunity Management V, LLC
10% Owner
+$1M
Feb 04, 2026
55,555 sh · $18.00
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Feb 06, 2026 | Column Group Opportunity III, LP10% Owner | 1,437,323 | $18.00 | +$25.9M |
| Feb 06, 2026 | Column Group Opportunity III, LP10% Owner | 630,881 | $18.00 | +$11.4M |
| Feb 06, 2026 | Column Group Opportunity III, LP10% Owner | 49,556 | $18.00 | +$892K |
| Feb 04, 2026 | Wolfe JoshDirector · 10% Owner | 138,888 | $18.00 | +$2.5M |
| Feb 04, 2026 | Frazier Kenneth CDirector | 111,111 | $18.00 | +$2M |
| Feb 04, 2026 | Foresite Capital Opportunity Management V, LLC10% Owner | 55,555 | $18.00 | +$1M |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Don't check EIKN — let it ping you
Watch every insider filing the minute it clears the SEC
The live dashboard reads every Form 4 as it lands and puts it in plain English — open-market buys, cluster buys where several insiders move at once, and the sales executives chose to make rather than scheduled. Free to open; Pro adds alerts, watchlists and each buyer's track record.
Eikon Therapeutics, Inc. is outside the ~660 companies InsiderPulse scans continuously. This page is built from the filings on the live tape and stays up while its insiders are buying. Monitoring, not advice.
Other companies insiders are buying now
Questions
- Are EIKN insiders buying or selling?
- Between Sep 03, 2026 and Sep 03, 2026, 1 Eikon Therapeutics, Inc. insider made 1 open-market purchase worth $1M and no sales, a net purchase of $1M.
- How much EIKN stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 4 Eikon Therapeutics, Inc. insiders made 6 open-market purchases worth $43.6M and no sales. In the four quarters to Jun 30, 2026: 6 purchases ($43.6M) and no sales. The largest purchase was Column Group Opportunity III, LP buying $25.9M on Feb 06, 2026.
- What was the largest recent EIKN insider trade?
- Column Group IV GP, LP (10% Owner) bought $1M of EIKN stock on Sep 03, 2026 at about $11.56 a share.
- When did an insider last buy EIKN shares?
- The most recent open-market purchase on file is Column Group IV GP, LP (10% Owner) buying $1M on Sep 03, 2026.
- Where does EIKN insider trading data come from?
- From the Form 4 filings Eikon Therapeutics, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
The week's real signals — open-market insider buys, cluster formations and what insiders did in EIKN and across the market — in plain English, with grants and routine vesting stripped out. Free, and honest about what the data can and cannot say.